This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Macfarlane D, Perry C, Fisher M. Diabetes for cardiologist. Chapter in Diabetic Cardiology. M Fisher, JJ McMurray, Editors. John Wiley & Sons: West Sussex 2007: 240-257MacfarlaneDPerryCFisherM.Diabetes for cardiologist. Chapter in Diabetic Cardiology. MFisherJJMcMurray, Editors. John Wiley & Sons: West Sussex2007: 240-257Search in Google Scholar
Wang CCL, Ness CN, Hiatt WR, Goldmine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus - Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations. Circulation. 2016;133:2459–2502WangCCLNessCNHiattWRGoldmineAB.Clinical Update: Cardiovascular Disease in Diabetes Mellitus - Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical Considerations. Circulation.2016;133:2459–250210.1161/CIRCULATIONAHA.116.022194491051027297342Search in Google Scholar
Sattar N. Cormack A. Pathogenesis of atherosclerosis and vascular disease in Type 2 diabetes. Chapter in Diabetic Cardiology. M Fisher, JJ McMurray, Editors. John Wiley & Sons: West Sussex 2007: 16-36SattarN.CormackA.Pathogenesis of atherosclerosis and vascular disease in Type 2 diabetes. Chapter in Diabetic Cardiology. MFisherJJMcMurray, Editors. John Wiley & Sons: West Sussex2007: 16-3610.1002/9780470723807.ch2Search in Google Scholar
Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1990). Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? Journal of the American Medical Association 1990; 263: 2893–2898HaffnerSMSternMPHazudaHPMitchellBDPattersonJK (1990). Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?Journal of the American Medical Association1990; 263: 2893–289810.1001/jama.1990.03440210043030Search in Google Scholar
WHO, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. 2006. Geneva: World Health Organization. Available at http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf. Accessed 11 Mar 2018,WHO, International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. 2006. Geneva: World Health Organization. Available at http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf. Accessed 11 Mar 2018,Search in Google Scholar
Colagiuri S, Davies D, Girgis S, Colagiuri R. National evidence based guideline for case detection and diagnosis of type 2 diabetes. Canberra: Diabetes Australia and the National Health and Medical Research Council, 2009. Available at http://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/af2389ea-8f61-4c54-82d6-77ab07f03597.pdf. Accessed 17 March 2018ColagiuriSDaviesDGirgisSColagiuriR.National evidence based guideline for case detection and diagnosis of type 2 diabetes. Canberra: Diabetes Australia and the National Health and Medical Research Council, 2009. Available at http://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/af2389ea-8f61-4c54-82d6-77ab07f03597.pdf. Accessed 17 March 2018Search in Google Scholar
American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018. Diabetes Care 2018 Jan; 41(Supplement 1): S13-S27. Available at http://care.diabetesjournals.org/content/41/Supplement_1/S13#T3. Accessed 11 Mar 2018American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018. Diabetes Care2018 Jan; 41(Supplement 1): S13-S27. Available at http://care.diabetesjournals.org/content/41/Supplement_1/S13#T3. Accessed 11 Mar 201810.2337/dc18-S00229222373Search in Google Scholar
International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327–34. Available at http://care.diabetesjournals.org/content/32/7/1327. Accessed 11 Mar 2018International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care2009; 32: 1327–34. Available at http://care.diabetesjournals.org/content/32/7/1327. Accessed 11 Mar 201810.2337/dc09-9033269971519502545Search in Google Scholar
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350. Available at http://www.nejm.org/doi/full/10.1056/NEJM200105033441801. Accessed 29 April 2017TuomilehtoJLindströmJErikssonJGValleTTHämäläinenHIlanne-ParikkaPKeinänen-KiukaanniemiSLaaksoMLouherantaARastasM.Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med2001;344:1343-1350. Available at http://www.nejm.org/doi/full/10.1056/NEJM200105033441801. Accessed 29 April 201710.1056/NEJM20010503344180111333990Search in Google Scholar
Di Pino A, Urbano F, Piro S, Purrello F, Rabuazzo AM. Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk. World J Diabetes 2016; 7(18): 423-432. Available at http://www.wjgnet.com/1948-9358/full/v7/i18/423.htm. Accessed 22 April 2017Di PinoAUrbanoFPiroSPurrelloFRabuazzoAM. Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk. World J Diabetes2016; 7(18): 423-432. Available at http://www.wjgnet.com/1948-9358/full/v7/i18/423.htm. Accessed 22 April 201710.4239/wjd.v7.i18.423506566227795816Search in Google Scholar
RACGP Guidelines for preventive activities in general practice 9th edition. Type 2 diabetes. Available at https://www.racgp.org.au/your-practice/guidelines/redbook/8-prevention-of-vascular-and-metabolic-disease/84-type-2-diabetes/. Accessed 3 Aug 18RACGP Guidelines for preventive activities in general practice 9th edition. Type 2 diabetes. Available at https://www.racgp.org.au/your-practice/guidelines/redbook/8-prevention-of-vascular-and-metabolic-disease/84-type-2-diabetes/. Accessed 3 Aug 18Search in Google Scholar
Cleland SJ, Shaw J. Prevention of diabetes as a means of preventing cardiovascular disease. Chapter in Diabetic Cardiology. M Fisher, JJ McMurray, Editors. John Wiley & Sons: West Sussex 2007: 240-257ClelandSJShawJ.Prevention of diabetes as a means of preventing cardiovascular disease. Chapter in Diabetic Cardiology. MFisherJJMcMurray, Editors. John Wiley & Sons: West Sussex2007: 240-25710.1002/9780470723807.ch10Search in Google Scholar
Determinants of Health. In Australia’s Health 2016, 15th biennial health report, Australian Institute of Health and Welfare, 2016. Available at http://aihw.gov.au/australias-health/2016/determinants/#t5. Accessed 17 April 2017.Determinants of Health. In Australia’s Health 2016, 15th biennial health report, Australian Institute of Health and Welfare, 2016. Available at http://aihw.gov.au/australias-health/2016/determinants/#t5. Accessed 17 April 2017.Search in Google Scholar
Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007; 49(4): 403–414GamiASWittBJHowardDEErwinPJGamiLAMetabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol.2007; 49(4): 403–41410.1016/j.jacc.2006.09.03217258085Search in Google Scholar
Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, et al. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834. Available at http://care.diabetesjournals.org/content/25/5/829.long. Accessed 25 April 2017DunstanDWZimmetPZWelbornTADe CourtenMPThe rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care2002; 25: 829-834. Available at http://care.diabetesjournals.org/content/25/5/829.long. Accessed 25 April 201710.2337/diacare.25.5.82911978676Search in Google Scholar
Phillips PJ. Oral glucose tolerance testing. Australian Family Physician 2012; 41: 391-393. Available at https://www.racgp.org.au/afp/2012/june/oral-glucose-tolerance-testing/#3. Accessed 12 March 2018PhillipsPJ.Oral glucose tolerance testing. Australian Family Physician2012; 41: 391-393. Available at https://www.racgp.org.au/afp/2012/june/oral-glucose-tolerance-testing/#3. Accessed 12 March 2018Search in Google Scholar
Periodic Examinations Requirements. Available at https://www.casa.gov.au/sites/g/files/net351/f/avmed/dames/handbook/images/avmed_reference_chart_2.png. Accessed 17 March 2018Periodic Examinations Requirements. Available at https://www.casa.gov.au/sites/g/files/net351/f/avmed/dames/handbook/images/avmed_reference_chart_2.png. Accessed 17 March 2018Search in Google Scholar
DAME Clinical Practice Guidelines: Hyperglycaemia - Initial Assessment. Available at https://www.casa.gov.au/licences-and-certification/aviation-medicine/hyperglycaemia-initial-assessment and https://www.casa.gov.au/licences-and-certification/aviation-medicine/hyperglycaemia-initial-assessment-flowchart-long. Accessed 8 March 2018DAME Clinical Practice Guidelines: Hyperglycaemia - Initial Assessment. Available at https://www.casa.gov.au/licences-and-certification/aviation-medicine/hyperglycaemia-initial-assessment and https://www.casa.gov.au/licences-and-certification/aviation-medicine/hyperglycaemia-initial-assessment-flowchart-long. Accessed 8 March 2018Search in Google Scholar
Warren B, Pankow JS, Matsushita K, et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2017; 5: 34–42 published online Nov 15. http://dx.doi.org/10.10162213-8587(16)30321-7WarrenBPankowJSMatsushitaKComparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol2017; 5: 34–42published online Nov 15. http://dx.doi.org/10.10162213-8587(16)30321-710.1016/S2213-8587(16)30321-7Search in Google Scholar
Makaroff LE. The need for international consensus on prediabetes. Lancet Diabetes Endocrinol. 2017;5:5–7MakaroffLE.The need for international consensus on prediabetes. Lancet Diabetes Endocrinol.2017;5:5–710.1016/S2213-8587(16)30328-XSearch in Google Scholar
Færch K, Hulmánb A, Solomon TPJ. Heterogeneity of Pre-diabetes and Type 2 Diabetes: Implications for Prediction, Prevention and Treatment Responsiveness. Current Diabetes Reviews, 2016, 12, 30-41. Available at http://www.eurekaselect.com/130419/article. Accessed 17 March 2018FærchKHulmánbASolomonTPJ.Heterogeneity of Pre-diabetes and Type 2 Diabetes: Implications for Prediction, Prevention and Treatment Responsiveness. Current Diabetes Reviews, 2016, 12, 30-41. Available at http://www.eurekaselect.com/130419/article. Accessed 17 March 201810.2174/157339981166615041612290325877695Search in Google Scholar
Barr EL, Boyko EJ, Zimmet PZ, et al. Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia 2009; 52(3): 415-24. Available at https://link.springer.com/article/10.1007%2Fs00125-008-1246-y. Accessed 17 March 2018BarrELBoykoEJZimmetPZContinuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia2009; 52(3): 415-24. Available at https://link.springer.com/article/10.1007%2Fs00125-008-1246-y. Accessed 17 March 201810.1007/s00125-008-1246-y19130039Search in Google Scholar
DECODE Study Group, European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161: 397–405DECODE Study Group, European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med2001;161: 397–40510.1001/archinte.161.3.39711176766Search in Google Scholar
Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 1999; 22:920–924. Available at http://care.diabetesjournals.org/content/22/6/920?ijkey=a40574c46b87dc11a94ee348ae2125a5d9749270&keytype2=tf_ipsecsha. Accessed 26 April 2017TominagaMEguchiHManakaHIgarashiKKatoTSekikawaA: Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care1999; 22:920–924. Available at http://care.diabetesjournals.org/content/22/6/920?ijkey=a40574c46b87dc11a94ee348ae2125a5d9749270&keytype2=tf_ipsecsha. Accessed 26 April 201710.2337/diacare.22.6.92010372242Search in Google Scholar
Huang Y, Cai X, Chen P, et al. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med 2014; 46: 684–92,HuangYCaiXChenPAssociations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med2014; 46: 684–92,10.3109/07853890.2014.95505125230915Search in Google Scholar
Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease. A systematic review of the evidence. J Am Coll Cardiol 2010; 55: 1310–17FordESZhaoGLiC.Pre-diabetes and the risk for cardiovascular disease. A systematic review of the evidence. J Am Coll Cardiol2010; 55: 1310–1710.1016/j.jacc.2009.10.06020338491Search in Google Scholar
Abdul-Ghani MA, Tripathy D, DeFronzo RA: Contributions of ß-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130-1139, 2006. Available at http://care.diabetesjournals.org/content/26/10/2910.long. Accessed 26 April 2017.Abdul-GhaniMATripathyDDeFronzoRA: Contributions of ß-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care29:1130-1139, 2006. Available at http://care.diabetesjournals.org/content/26/10/2910.long. Accessed 26 April 2017.10.2337/dc05-2179Search in Google Scholar
DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol. 2011;108:3B-24B.DeFronzoRAAbdul-GhaniM.Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol.2011;108:3B-24B.10.1016/j.amjcard.2011.03.01321802577Search in Google Scholar
Qiao Q, Jousilahti P, Eriksson J, Tuomilehto J. Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care 26:2910-2914, 2003. Available at http://care.diabetesjournals.org/content/29/5/1130.long. Accessed 26 April 2017QiaoQJousilahtiPErikssonJTuomilehtoJ.Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up. Diabetes Care26:2910-2914, 2003. Available at http://care.diabetesjournals.org/content/29/5/1130.long. Accessed 26 April 201710.2337/diacare.26.10.2910Search in Google Scholar
Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H. Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose: Summary. AHRQ Evidence Report Summaries. Agency for Healthcare Research and Quality (US); Rockville: MD. 2005. Available at https://www.ncbi.nlm.nih.gov/books/NBK11923/. Accessed 25 April 2017SantaguidaPLBalionCHuntDMorrisonKGersteinHRainaPBookerLYazdiH.Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose: Summary. AHRQ Evidence Report Summaries. Agency for Healthcare Research and Quality (US); Rockville: MD. 2005. Available at https://www.ncbi.nlm.nih.gov/books/NBK11923/. Accessed 25 April 2017Search in Google Scholar
Huang Y, Cai X, Chen P, et al. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med 2014; 46: 684–92HuangYCaiXChenPAssociations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med2014; 46: 684–9210.3109/07853890.2014.955051Search in Google Scholar
Færch K, Bergman B, Perreault L. Does insulin resistance drive the association between hyperglycemia and cardiovascular risk? PLoS ONE 2012; 7(6): e39260. Available at http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0039260. Accessed 17 March 2018FærchKBergmanBPerreaultL.Does insulin resistance drive the association between hyperglycemia and cardiovascular risk?PLoS ONE2012; 7(6): e39260. Available at http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0039260. Accessed 17 March 201810.1371/journal.pone.0039260Search in Google Scholar
Fiorentino TV, Marini MA, Andreozzi F, Arturi F, Succurro E, Perticone M, Sciacqua A, Hribal ML, Perticone F, Sesti G. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. J Clin Endocrinol Metab. 2015;100:3744-3751. Available at https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2015-2573. Accessed 26 April 2017FiorentinoTVMariniMAAndreozziFArturiFSuccurroEPerticoneMSciacquaAHribalMLPerticoneFSestiG.One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. J Clin Endocrinol Metab.2015;100:3744-3751. Available at https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2015-2573. Accessed 26 April 201710.1210/jc.2015-2573Search in Google Scholar
Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care. 2010; 33:562-568. Available at http://care.diabetesjournals.org/content/33/3/5 62.long. Accessed 30 April 2017CowieCCRustKFByrd-HoltDDGreggEWFordESGeissLSBainbridgeKEFradkinJE.Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care.2010; 33:562-568. Available at http://care.diabetesjournals.org/content/33/3/5 62.long. Accessed 30 April 201710.2337/dc09-1524Search in Google Scholar
Heianza Y, Hara S, Arase Y, Saito K, Fujiwara K, Tsuji H, Kodama S, Hsieh SD, Mori Y, Shimano H. HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet. 2011;378:147-155HeianzaYHaraSAraseYSaitoKFujiwaraKTsujiHKodamaSHsiehSDMoriYShimanoH.HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet.2011;378:147-15510.1016/S0140-6736(11)60472-8Search in Google Scholar
Mann DM, Carson AP, Shimbo D, Fonseca V, Fox CS, Muntner P. Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. Adults. Diabetes Care. 2010;33:2190-2195. Available at http://care.diabetesjournals.org/content/33/10/2190.long. Accessed 30 April 2017MannDMCarsonAPShimboDFonsecaVFoxCSMuntnerP.Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. Adults. Diabetes Care.2010;33:2190-2195. Available at http://care.diabetesjournals.org/content/33/10/2190.long. Accessed 30 April 201710.2337/dc10-0752294515920628087Search in Google Scholar
Yan ST, Xiao HY, Tian H, Li CL, Fang FS, Li XY, Cheng XL, Li N, Miao XY, Yang Y. The cutoffs and performance of glycated hemoglobin for diagnosing diabetes and prediabetes in a young and middle-aged population and in an elderly population. Diabetes Res Clin Pract. 2015;109:238-245YanSTXiaoHYTianHLiCLFangFSLiXYChengXLLiNMiaoXYYangY.The cutoffs and performance of glycated hemoglobin for diagnosing diabetes and prediabetes in a young and middle-aged population and in an elderly population. Diabetes Res Clin Pract.2015;109:238-24510.1016/j.diabres.2015.05.04726059072Search in Google Scholar
Paprott R, Schaffrath Rosario A, Busch MA, et al. Association Between Hemoglobin A1c and All-Cause Mortality: Results of the Mortality Follow-up of the German National Health Interview and Examination Survey 1998. Diabetes Care 2015; 38(2): 249-56. Available at http://care.diabetesjournals.org/content/38/2/249. Accessed 17 March 2018PaprottRSchaffrath RosarioABuschMAAssociation Between Hemoglobin A1c and All-Cause Mortality: Results of the Mortality Follow-up of the German National Health Interview and Examination Survey 1998. Diabetes Care2015; 38(2): 249-56. Available at http://care.diabetesjournals.org/content/38/2/249. Accessed 17 March 201810.2337/dc14-178725414153Search in Google Scholar
Valenti V, Hartaigh Bó, Heo R, Cho I, Schulman-Marcus J, et al. A 15-year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of 9715 individuals. JACC Cardiovasc Imaging. 2015; 8(8): 900-909ValentiVHartaighBóHeoRChoISchulman-MarcusJA 15-year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of 9715 individuals. JACC Cardiovasc Imaging.2015; 8(8): 900-90910.1016/j.jcmg.2015.01.025453735726189116Search in Google Scholar
RACGP Clinical Guidelines. General Practice Management of type 2 diabetes: Identifying risk of diabetes in asymptomatic patients. Available at https://www.racgp.org.au/your-practice/guidelines/diabetes/3-screening,-risk-assessment,-case-finding-and-diagnosis/31-identifying-risk-of-diabetes-in-asymptomatic-patients/. Accessed 12 Mar 2018RACGP Clinical Guidelines. General Practice Management of type 2 diabetes: Identifying risk of diabetes in asymptomatic patients. Available at https://www.racgp.org.au/your-practice/guidelines/diabetes/3-screening,-risk-assessment,-case-finding-and-diagnosis/31-identifying-risk-of-diabetes-in-asymptomatic-patients/. Accessed 12 Mar 2018Search in Google Scholar
DAME Clinical Practice Guidelines – Obesity. Available at https://www.casa.gov.au/licences-and-certification/aviation-medicine/obesity. Accessed 17 March 2018DAME Clinical Practice Guidelines – Obesity. Available at https://www.casa.gov.au/licences-and-certification/aviation-medicine/obesity. Accessed 17 March 2018Search in Google Scholar
Metabolic, nutritional and endocrine diseases – Diabetes Mellitus. Chapter in Manual of Civil Aviation Medicine. Doc 8984. International Civil Aviation Organization, 3rd edition; 2012; III-4-14 – III-4-22Metabolic, nutritional and endocrine diseases – Diabetes Mellitus. Chapter in Manual of Civil Aviation Medicine. Doc 8984. International Civil Aviation Organization, 3rd edition; 2012; III-4-14 – III-4-22Search in Google Scholar
Ministry of Health. Cardiovascular Disease Risk Assessment and Management for Primary Care. Wellington: Ministry of Health; 2018. Available at https://www.health.govt.nz/publication/cardioVascular-disease-risk-assessment-and-management-primary-care. Accessed 16 June 2018Ministry of Health. Cardiovascular Disease Risk Assessment and Management for Primary Care. Wellington: Ministry of Health; 2018. Available at https://www.health.govt.nz/publication/cardioVascular-disease-risk-assessment-and-management-primary-care. Accessed 16 June 2018Search in Google Scholar
